đź“‹ FDA Reference

Modification to Amphirion Deep 0 014 OTW PTA Balloon Catheter

Invatec Innovative Technologies, S.R.L.

Compare similar devices

Summary: The Amphirion Deep 0.014 OTW PTA Balloon Catheter is a medical device used for percutaneous transluminal angioplasty (PTA) procedures. It is primarily utilized by interventional radiologists and vascular surgeons to treat venous stenosis.

FDA Clearance Information

Pathway ? 510(k)
Number ? K052791 ↗
Decision Date ? November 4, 2005
Product Code ? DQY Catheter, Percutaneous
Device Class ? Class 2
Evidence ? 0 studies

The Amphirion Deep 0.014 OTW PTA Balloon Catheter was cleared through the FDA 510(k) pathway on November 4, 2005, by Invatec Innovative Technologies, S.R.L. It is classified as a Class 2 device under product code DQY.

What It Is

The Amphirion Deep 0.014 OTW PTA Balloon Catheter is a specialized catheter designed for use in percutaneous transluminal angioplasty (PTA) procedures. It features an over-the-wire (OTW) design that allows for precise navigation through blood vessels. The balloon can be inflated to dilate narrowed sections of veins, improving blood flow and reducing symptoms associated with venous stenosis.

FDA-Cleared Indications

  • Use during percutaneous transluminal angioplasty of narrowed peripheral blood vessels.
  • Dilation of stenotic lesions in peripheral vessels when treatment with a balloon catheter is clinically appropriate.

Clinical Applications

  • Balloon angioplasty of peripheral vascular stenoses.
  • Dilation of narrowed vessels before or during peripheral vascular intervention.
  • Lesion preparation before placement of a peripheral vascular stent when clinically indicated.
  • Treatment of peripheral vascular narrowing in a catheterization laboratory or hospital-based interventional setting.

Reported off-label uses

  • Use in selected venous stenoses, including dialysis-access or central venous narrowing, may occur in clinical practice but should be considered off-label unless specifically included in the applicable device labeling.
  • Use in vessel territories, lesion types, or procedural techniques outside the FDA-cleared labeling is off-label and requires physician judgment, institutional review, and informed consent.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The device uses an over-the-wire design and requires a compatible guidewire and vascular access system; clinicians should verify the catheter and guidewire specifications before use.
  • Available balloon diameters and lengths vary by configuration, so the selected size must match the target vessel and lesion.
  • Use fluoroscopic or other appropriate imaging guidance, careful lesion crossing, and controlled balloon inflation according to the manufacturer’s instructions for use.
  • MRI safety depends on the exact device configuration and labeling; the device should not be considered MRI safe or MRI conditional without confirming the current manufacturer’s instructions.
  • Contraindications and precautions include inability to safely cross the lesion, unsuitable vessel anatomy, severe access-site disease, and patient or lesion factors that increase the risk of dissection, perforation, thrombosis, or bleeding.

Procedures that use this device

Frequently Asked Questions

What is Amphirion Deep 0.014 OTW PTA Balloon Catheter used for?

It is used for percutaneous transluminal angioplasty (PTA) to treat venous stenosis.

What specialties typically use this device?

Interventional radiologists and vascular surgeons commonly use this device.

What are the FDA-cleared indications?

The device is indicated for the treatment of narrowed or blocked veins to improve blood flow.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you